HRS4R
Vull donar

FRANCISCO JOSÉ ORTEGA DELGADO

Firma
FRANCISCO JOSÉ ORTEGA-DELGADO
Posició
Investigador/a Consolidat - R3
Investigador/a Consolidat - R3
curriculum

Projectes

Codi oficial: AC18/00012 Data inici: 01/01/2019 Data fi: 30/06/2023 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 149,998.86 €
Codi oficial: FI19/00045 Data inici: 01/01/2020 Data fi: 31/12/2023 Investigador/a principal: FRANCISCO JOSÉ ORTEGA DELGADO Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 82,400 €
Codi oficial: MS19/00109 Data inici: 01/01/2020 Data fi: 31/12/2024 Investigador/a principal: FRANCISCO JOSÉ ORTEGA DELGADO Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 202,500 €
Codi oficial: PI21/00074 Data inici: 01/01/2022 Data fi: 31/12/2024 Investigador/a principal: FRANCISCO JOSÉ ORTEGA DELGADO Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 145,200 €
Codi oficial: MV22/00074 Aina Lluch Data inici: 27/02/2023 Data fi: 26/07/2023 Investigador/a principal: FRANCISCO JOSÉ ORTEGA DELGADO Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 17,250 €

Publicacions

Rodríguez-Barrueco R, Latorre J, Devis-Jáuregui L, Lluch A, Bonifaci N, Llobet FJ, Olivan M, Coll-Iglesias L, Gassner K, Davis ML, Moreno-Navarrete JM, Castells-Nobau A, Plata-Peña L, Dalmau-Pastor M, Höring M, Liebisch G, Olkkonen VM, Arnoriaga-Rodríguez M, Ricart W, Fernández-Real JM, Silva JM, Ortega FJ, Llobet-Navas D

A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG.

Advanced Science, 2022, 9 dx.doi.org/10.1002/advs.202104759

Latorre J, Ortega F, Oliveras-Cañellas N, Comas F, Lluch A, Gavaldà-Navarro A, Morón-Ros S, Ricart W, Villarroya F, Giralt M, Fernández-Real JM, Moreno-Navarrete JM

Specific adipose tissue Lbp gene knockdown prevents diet-induced body weight gain, impacting fat accretion-related gene and protein expression.

MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 27, 870-879 dx.doi.org/10.1016/j.omtn.2022.01.002
0

Downregulation of peripheral lipopolysaccharide binding protein impacts on perigonadal adipose tissue only in female mice.

BIOMEDICINE & PHARMACOTHERAPY, 2022, 151, 113156-113156 dx.doi.org/10.1016/j.biopha.2022.113156
0

Downregulation of hepatic lipopolysaccharide binding protein improves lipogenesis-induced liver lipid accumulation.

MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 29, 599-613 dx.doi.org/10.1016/j.omtn.2022.08.003
0

Serum neuregulin 4 is negatively correlated with insulin sensitivity in humans and impairs mitochondrial respiration in HepG2 cells.

FRONTIERS IN PHYSIOLOGY, 2022, 13, 950791-950791 dx.doi.org/10.3389/fphys.2022.950791
0

A compound directed against S6K1 hampers fat mass expansion and mitigates diet-induced hepatosteatosis.

JCI Insight, 2022, 7 dx.doi.org/10.1172/jci.insight.150461
0

Adipose tissue cysteine dioxygenase type 1 is associated with an anti-inflammatory profile, impacting on systemic metabolic traits.

EBioMedicine, 2022, 85, 104302-104302 dx.doi.org/10.1016/j.ebiom.2022.104302
0

Olfactomedin 2 deficiency protects against diet-induced obesity.

METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 129, 155122-155122 dx.doi.org/10.1016/j.metabol.2021.155122

Moreno-Navarrete JM, Latorre J, Lluch A, Ortega FJ, Comas F, Arnoriaga-Rodríguez M, Ricart W, Fernández-Real JM

Lysozyme is a component of the innate immune system linked to obesity associated-chronic low-grade inflammation and altered glucose tolerance.

CLINICAL NUTRITION, 2021, 40, 1420-1429 dx.doi.org/10.1016/j.clnu.2020.08.036

Comas F, Latorre J, Ortega F, Oliveras-Cañellas N, Lluch A, Ricart W, Fernández-Real JM, Moreno-Navarrete JM

Permanent cystathionine-ß-Synthase gene knockdown promotes inflammation and oxidative stress in immortalized human adipose-derived mesenchymal stem cells, enhancing their adipogenic capacity.

Redox Biology, 2021, 42, 101668-101668 dx.doi.org/10.1016/j.redox.2020.101668

Formulari de contacte

Coneix l’IDIBGI!

menu